Drugs: from discovery to approval
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Hoboken, New Jersey
John Wiley & Sons, Inc.
[2015]
|
| Ausgabe: | Third edition |
| Schlagworte: | |
| Beschreibung: | Description based on print version record |
| Beschreibung: | 1 online resource (xvi, 536 pages.) |
| ISBN: | 9781118907221 1118907221 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV045463505 | ||
| 003 | DE-604 | ||
| 005 | 20220308 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190214s2015 |||| o||u| ||||||eng d | ||
| 020 | |a 9781118907221 |c electronic bk. |9 978-1-118-90722-1 | ||
| 020 | |a 1118907221 |c electronic bk. |9 1-118-90722-1 | ||
| 035 | |a (ZDB-4-NLEBK)981389 | ||
| 035 | |a (OCoLC)912961041 | ||
| 035 | |a (DE-599)BVBBV045463505 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-91 | ||
| 082 | 0 | |a 615.1/9 |2 23 | |
| 100 | 1 | |a Ng, Rick |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Drugs |b from discovery to approval |c Rick Ng |
| 250 | |a Third edition | ||
| 264 | 1 | |a Hoboken, New Jersey |b John Wiley & Sons, Inc. |c [2015] | |
| 300 | |a 1 online resource (xvi, 536 pages.) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Description based on print version record | ||
| 650 | 4 | |a Drug Discovery | |
| 650 | 4 | |a Chemistry, Pharmaceutical | |
| 650 | 4 | |a Clinical Trials as Topic / methods | |
| 650 | 4 | |a Drug Approval / legislation & jurisprudence | |
| 650 | 4 | |a Drug Approval / methods | |
| 650 | 4 | |a Technology, Pharmaceutical | |
| 650 | 4 | |a Drug development |a Pharmaceutical chemistry |a Drugs |x Testing |a Drug approval |a Pharmaceutical technology | |
| 650 | 0 | 7 | |a Pharmazeutische Technologie |0 (DE-588)4045699-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimitteldesign |0 (DE-588)4278218-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelprüfung |0 (DE-588)4128030-1 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Arzneimitteldesign |0 (DE-588)4278218-1 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 689 | 1 | 0 | |a Arzneimittelprüfung |0 (DE-588)4128030-1 |D s |
| 689 | 1 | |8 2\p |5 DE-604 | |
| 689 | 2 | 0 | |a Pharmazeutische Technologie |0 (DE-588)4045699-7 |D s |
| 689 | 2 | |8 3\p |5 DE-604 | |
| 689 | 3 | 0 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 3 | |8 4\p |5 DE-604 | |
| 776 | 0 | 8 | |i Online version |a Ng, Rick, author |t Drugs |b Third edition |d Hoboken, New Jersey : John Wiley & Sons, Inc., [2015] |z 9781118907191 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781118907276 |z 1118907272 |
| 912 | |a ZDB-4-NLEBK | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-030848728 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 3\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 4\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
Datensatz im Suchindex
| _version_ | 1804179367721435136 |
|---|---|
| any_adam_object | |
| author | Ng, Rick |
| author_facet | Ng, Rick |
| author_role | aut |
| author_sort | Ng, Rick |
| author_variant | r n rn |
| building | Verbundindex |
| bvnumber | BV045463505 |
| collection | ZDB-4-NLEBK |
| ctrlnum | (ZDB-4-NLEBK)981389 (OCoLC)912961041 (DE-599)BVBBV045463505 |
| dewey-full | 615.1/9 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.1/9 |
| dewey-search | 615.1/9 |
| dewey-sort | 3615.1 19 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | Third edition |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02587nmm a2200625zc 4500</leader><controlfield tag="001">BV045463505</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20220308 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190214s2015 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781118907221</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-1-118-90722-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1118907221</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">1-118-90722-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-4-NLEBK)981389</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)912961041</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV045463505</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-91</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.1/9</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ng, Rick</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Drugs</subfield><subfield code="b">from discovery to approval</subfield><subfield code="c">Rick Ng</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">Third edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Hoboken, New Jersey</subfield><subfield code="b">John Wiley & Sons, Inc.</subfield><subfield code="c">[2015]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xvi, 536 pages.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Description based on print version record</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Discovery</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chemistry, Pharmaceutical</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trials as Topic / methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Approval / legislation & jurisprudence</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Approval / methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Technology, Pharmaceutical</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug development</subfield><subfield code="a">Pharmaceutical chemistry</subfield><subfield code="a">Drugs</subfield><subfield code="x">Testing</subfield><subfield code="a">Drug approval</subfield><subfield code="a">Pharmaceutical technology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Technologie</subfield><subfield code="0">(DE-588)4045699-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimitteldesign</subfield><subfield code="0">(DE-588)4278218-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelprüfung</subfield><subfield code="0">(DE-588)4128030-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimitteldesign</subfield><subfield code="0">(DE-588)4278218-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Arzneimittelprüfung</subfield><subfield code="0">(DE-588)4128030-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Pharmazeutische Technologie</subfield><subfield code="0">(DE-588)4045699-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="8">3\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="8">4\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Online version</subfield><subfield code="a">Ng, Rick, author</subfield><subfield code="t">Drugs</subfield><subfield code="b">Third edition</subfield><subfield code="d">Hoboken, New Jersey : John Wiley & Sons, Inc., [2015]</subfield><subfield code="z">9781118907191</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781118907276</subfield><subfield code="z">1118907272</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-NLEBK</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030848728</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">4\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
| id | DE-604.BV045463505 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:18:45Z |
| institution | BVB |
| isbn | 9781118907221 1118907221 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030848728 |
| oclc_num | 912961041 |
| open_access_boolean | |
| owner | DE-91 DE-BY-TUM |
| owner_facet | DE-91 DE-BY-TUM |
| physical | 1 online resource (xvi, 536 pages.) |
| psigel | ZDB-4-NLEBK |
| publishDate | 2015 |
| publishDateSearch | 2015 |
| publishDateSort | 2015 |
| publisher | John Wiley & Sons, Inc. |
| record_format | marc |
| spelling | Ng, Rick Verfasser aut Drugs from discovery to approval Rick Ng Third edition Hoboken, New Jersey John Wiley & Sons, Inc. [2015] 1 online resource (xvi, 536 pages.) txt rdacontent c rdamedia cr rdacarrier Description based on print version record Drug Discovery Chemistry, Pharmaceutical Clinical Trials as Topic / methods Drug Approval / legislation & jurisprudence Drug Approval / methods Technology, Pharmaceutical Drug development Pharmaceutical chemistry Drugs Testing Drug approval Pharmaceutical technology Pharmazeutische Technologie (DE-588)4045699-7 gnd rswk-swf Arzneimitteldesign (DE-588)4278218-1 gnd rswk-swf Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf Arzneimittelprüfung (DE-588)4128030-1 gnd rswk-swf Arzneimitteldesign (DE-588)4278218-1 s 1\p DE-604 Arzneimittelprüfung (DE-588)4128030-1 s 2\p DE-604 Pharmazeutische Technologie (DE-588)4045699-7 s 3\p DE-604 Arzneimittelentwicklung (DE-588)4143176-5 s 4\p DE-604 Online version Ng, Rick, author Drugs Third edition Hoboken, New Jersey : John Wiley & Sons, Inc., [2015] 9781118907191 Erscheint auch als Druck-Ausgabe 9781118907276 1118907272 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 3\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 4\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Ng, Rick Drugs from discovery to approval Drug Discovery Chemistry, Pharmaceutical Clinical Trials as Topic / methods Drug Approval / legislation & jurisprudence Drug Approval / methods Technology, Pharmaceutical Drug development Pharmaceutical chemistry Drugs Testing Drug approval Pharmaceutical technology Pharmazeutische Technologie (DE-588)4045699-7 gnd Arzneimitteldesign (DE-588)4278218-1 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd Arzneimittelprüfung (DE-588)4128030-1 gnd |
| subject_GND | (DE-588)4045699-7 (DE-588)4278218-1 (DE-588)4143176-5 (DE-588)4128030-1 |
| title | Drugs from discovery to approval |
| title_auth | Drugs from discovery to approval |
| title_exact_search | Drugs from discovery to approval |
| title_full | Drugs from discovery to approval Rick Ng |
| title_fullStr | Drugs from discovery to approval Rick Ng |
| title_full_unstemmed | Drugs from discovery to approval Rick Ng |
| title_short | Drugs |
| title_sort | drugs from discovery to approval |
| title_sub | from discovery to approval |
| topic | Drug Discovery Chemistry, Pharmaceutical Clinical Trials as Topic / methods Drug Approval / legislation & jurisprudence Drug Approval / methods Technology, Pharmaceutical Drug development Pharmaceutical chemistry Drugs Testing Drug approval Pharmaceutical technology Pharmazeutische Technologie (DE-588)4045699-7 gnd Arzneimitteldesign (DE-588)4278218-1 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd Arzneimittelprüfung (DE-588)4128030-1 gnd |
| topic_facet | Drug Discovery Chemistry, Pharmaceutical Clinical Trials as Topic / methods Drug Approval / legislation & jurisprudence Drug Approval / methods Technology, Pharmaceutical Drug development Pharmaceutical chemistry Drugs Testing Drug approval Pharmaceutical technology Pharmazeutische Technologie Arzneimitteldesign Arzneimittelentwicklung Arzneimittelprüfung |
| work_keys_str_mv | AT ngrick drugsfromdiscoverytoapproval |